Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

319 ARTÍCULOS , VIENDO DEL 46 AL 60

Sleep Spindles and Slow Oscillations as Potential Biomarkers and Therapeutic Targets in Mild-to-Moderate Alzheimer's Disease

Páez A, Piñol-Ripoll G, Dakterzada F, Dang-Vu TT.

Curr Neurol Neurosci Rep. 2026 Oct 20;26(1):58. doi: 10.1007/s11910-026-01528-9.

More than just accuracy: A pathway-level framework for implementing blood and digital biomarkers for Alzheimer's disease care

Perneczky R, Schöll M, Rauchmann BS, Hofmann A.

Neuron. 2026 Oct 20:S0896-6273(26)00689-6. doi: 10.1016/j.neuron.2026.09.006. Online ahead of print.

Biomarker profiles in late-life depression and Alzheimer's disease across and beyond the A/T/N framework: A scoping review

Zhu Y, Damera N, Singh RK, Bekena S, Kelble L, McGuire K, Hu Y, Mersiehazen E, Vijay G, Nazif A, Kolady R, Xiang L, Liu X, Flores S, Dombrowski K, Pal S, Hardi A, Taylor K, Trani JF, Ances BM, Lenze EJ, Vemuri P, Jack CR Jr, Petersen RC, Babulal GM.

Alzheimers Dement. 2026 Oct;22(10):e71739. doi: 10.1002/alz.71739.

Osteoporosis and Alzheimer's Disease: The Role of Sclerostin

Gagiano L, Chen Z, Blakeney WG, Jones C, Mastaglia F, Zheng M, Yuan J.

Curr Osteoporos Rep. 2026 Oct 21;24(1):44. doi: 10.1007/s11914-026-00993-y.

Association Between Plasma N-Terminal Tau, Cognitive Decline, and Neurodegeneration in the ADNI Cohort

Rao Y, Liu L, Ostaszewski BL, Anderson AK, Pinilla V, Shirzadi Z, Laho EM, Stern AM, Yau WW, Yang HS, Buckley RF, Ashton NJ, Denkinger MN, Sperling RA, Selkoe DJ, Chhatwal JP, Schultz SA; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2026 Nov 24;107(10):e218564. doi: 10.1212/WNL.0000000000218564. Epub 2026 Oct 21.

Real-world safety and efficacy of lecanemab in the treatment of Alzheimer's disease: a systematic review and meta-analysis

Wu Y, Zhu L, Chen J, Liu J, Yin K, Yang X.

J Neurol. 2026 Oct 21;273(11):675. doi: 10.1007/s00415-026-14224-y.

Chromosome 21 gene dosage and Alzheimer's disease in Down syndrome: DYRK1A mechanism and its translation to blood-based biomarkers

Shateri A.

J Alzheimers Dis. 2026 Oct 22:13872877261499713. doi: 10.1177/13872877261499713. Online ahead of print.

Noninvasive diagnosis of Alzheimer's disease: a review of emerging biomarkers and multimodal approaches

Zhao J, Nie C, Gao R, Hu Z, Lin Y.

Front Cell Dev Biol. 2026 Oct 8;14:1964029. doi: 10.3389/fcell.2026.1964029. eCollection 2026.

Continuous amyloid staging complements global amyloid burden in early Alzheimer's disease

Liu H, Tong M, Fang S, Mormino EC, Sperling RA, Aisen P, Buckley RF, Crane PK, Hohman TJ, Saykin AJ, Yan J; Alzheimer’s Disease Neuroimaging Initiative.

bioRxiv [Preprint]. 2026 Oct 11:2026.10.03.756367. doi: 10.64898/2026.10.03.756367.

Clinical utility of plasma APOE proteotyping for Alzheimer's disease risk and prognosis

Shi R, Choity LT, Farinas MF, Zeng X, Emanuel JE, Saeed A, Reis SE, Lopez OL, Kamboh MI, Cohen AD, Gildengers AG, Wilckens KA, Karikari TK.

medRxiv [Preprint]. 2026 Oct 11:2026.10.08.26364972. doi: 10.64898/2026.10.08.26364972.

Plasma eMTBR-tau as a robust biomarker for Alzheimer's disease tangle pathology up to 10 years before death

Shi R, Zeng X, Farinas MF, Nafash MN, Smirnov DS, Kamboh MI, Snitz BE, Kofler JK, Cohen AD, Pascoal TA, Ikonomovic MD, Zetterberg H, Lopez OL, Karikari TK.

medRxiv [Preprint]. 2026 Oct 5:2026.09.29.26363951. doi: 10.64898/2026.09.29.26363951.

Locus coeruleus intensity as a marker of early-stage Alzheimer's disease: associations with plasma pTau (217) and memory

Quiring M, Shuai Y, Zhao W, Alitin JPM, Kapoor A, Engstrom AC, Joyce JL, Iyengar P, Lohman T, Lashin B, Gaubert A, Shenasa F, Contreras L, Law KW, Ferrer F, Wang DJJ, Head E, Malhas R, Rodgers K, Han SD, Thayer JF, Bondi MW, Mather M, Nation DA.

medRxiv [Preprint]. 2026 Oct 9:2026.10.07.26364896. doi: 10.64898/2026.10.07.26364896.

Real-world clinical, biomarker, and imaging outcomes of lecanemab in Alzheimer's disease: a multicenter longitudinal cohort study in Jiangsu, China

Tang L, Chen X, Zhang L, Fan L, Chen N, Li C, Cai Z, Chen G, Chen H, Ye M, Zheng H, Li Q, Ke Z, Hu Z, Cao M, Yang D, Xu S, Xie C, Li X, Xu X, Yu M, Lian X, Hu H, Li H, Cai X, Chen H, Xu W, Cui G, Zhao Y, Dong J, Zhang L, Zhu X, Zhao H, Xu Y.

Alzheimers Dement. 2026 Oct;22(10):e71936. doi: 10.1002/alz.71936.

Pathway-specific polygenic risk scores modify the association between amyloid and tau PET accumulation in patients with Alzheimer's disease

Valentim C, Denecke J, Frerich S, Betthauser TJ, Li Y, Ahmadi R, Franzmeier N; Alzheimer's Disease Neuroimaging Initiative (ADNI); Malik R, Ewers M.

Alzheimers Dement. 2026 Oct;22(10):e71939. doi: 10.1002/alz.71939.

Circular RNAs in Alzheimer's Disease: Mechanisms, Biomarkers, and EPAC Signalling in Ferroptosis

Yüksel M, Schmidt M.

Antioxidants (Basel). 2026 Oct 13;15(10):1321. doi: 10.3390/antiox15101321.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias